Target intelligence / Profile preview

Multimerin-1 (MMRN1)

Target
MMRN1
Molecular classification
Adhesive extracellular matrix glycoprotein, EMILIN (Elastin Microfibril Interface Located Protein) family member, Multimeric blood protein, Platelet granule protein
01

Overview

Multimerin-1 (MMRN1) is a large, soluble, disulfide-linked multimeric glycoprotein primarily expressed in platelets, megakaryocytes, and endothelial cells, and is a member of the EMILIN protein family. It is stored in platelet alpha granules and endothelial storage granules, released upon activation, and is not normally detectable in plasma. MMRN1 acts as a major adhesive molecule, supporting platelet adhesion and aggregate formation by binding to von Willebrand factor, fibrillar collagen (notably at GPAGPOGPX motifs), and coagulation Factor V, thereby critically influencing haemostasis, thrombosis, and vascular repair. Its functions extend to modulation of thrombin generation and adhesion of platelets and endothelial cells, and it is implicated in angiogenesis and pathological contexts such as cancer and cardiovascular disease. The molecular structure includes distinctive EMILIN-family domains, an EGF-like domain, and an RGD motif, with unclear but highly relevant roles in protein-protein interaction and vascular physiology. MMRN1 is not the same as Glycoprotein Ia (GPIa, α2β1 integrin), and aliases containing "GPIa" are likely cross-references or errors in existing nomenclature databases for this context.

Other names
Multimerin 1Multimerin-1Platelet multimerin155 kDa platelet multimerinECM EMILIN4EMILIN4MMRNElastin microfibril interfacer 4p155Endothelial cell multimerinelastin microfibril interface located protein 4EMILIN family protein
02

Mechanism of action

For drugs affecting coagulation or platelet activation: may indirectly affect MMRN1 release, function, or its interactions with Factor V and von Willebrand factor. No drugs known to use direct MMRN1 inhibition or activation as a primary mechanism.

03

Biological functions

Supports and regulates platelet adhesion to collagen and other proteins during haemostasis and thrombosisBinds von Willebrand factor, modulating platelet functionBinds to and regulates Factor V in platelets, modulating thrombin productionContributes to vascular homeostasis and endothelial interactionsParticipates in angiogenesis and coagulation cascade
04

Disease associations

Cardiovascular disease (promotes or modulates thrombus formation, vascular haemostasis)Cancer (expression altered in certain malignancies, possibly influences tumour progression or angiogenesis)Potential roles in inflammation (as part of platelet and endothelial cellular response)
05

Safety considerations

Therapeutic targeting is challenged by broad role in haemostasis and thrombosis, which risks bleeding or thrombotic complicationsUnintended modulation could destabilize normal platelet or endothelial function, impacting clot formation or resolution
06

Interacting drugs

No approved drugs directly reported that target Multimerin-1 as a mechanism. However, modulators affecting platelet function, coagulation, or von Willebrand factor (such as antiplatelet agents, Factor V modulators, hemostatic agents) could have indirect effects on MMRN1-mediated pathways as part of broader effects.
07

Biomarkers

MMRN1 levels and expression patterns have been studied as potential biomarkers for platelet granule function, endothelial activation, and possibly cancer progressionMay serve as a biomarker for platelet alpha granule content/function and vascular injury

Beyond the preview

Go deeper on Multimerin-1 (MMRN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multimerin-1 (MMRN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call